Atraric acid
Product Specifications
CAS Number
4707-47-5
Target
Phosphatase, Androgen Receptor, p38 MAPK, NF-κB, NO Synthase
Related Pathways
Endocrinology/Hormones, Metabolism, MAPK, NF-κB, Immunology/Inflammation
Purity
0.9959
Bioactivity
Atraric acid derivatives as a new chemical lead structure for novel therapeutic compounds as AR antagonists, that can be used for prophylaxis or treatment of prostatic diseases. It inhibits PTP1B activity in a dose-dependent manner with IC50 values of 51.5 uM, suggest that atraric acid has potential to treat diabetes.
Smiles
COC(=O)C1=C(O)C(C)=C(O)C=C1C
Molecular Formula
C10H12O4
Molecular Weight
196.2
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
GTR15102977 1 Vial
Lentiviral human SMCO3 shRNA (UAS) - Lentiviral human SMCO3 shRNA (UAS) (25)
Sign In for Pricing
View Details 
TMPY-01029-01 5 µg
RELT/TNFRSF19L Protein, Human, Recombinant (His & hFc)
Sign In for Pricing
View Details TMPY-01029-02 10 µg
RELT/TNFRSF19L Protein, Human, Recombinant (His & hFc)
Sign In for Pricing
View Details TMPY-01029-03 20 µg
RELT/TNFRSF19L Protein, Human, Recombinant (His & hFc)
Sign In for Pricing
View Details